Latest Articles on Partnering Interests
![central nervous system diseases graphic central nervous system diseases graphic](/sites/default/files/us/2023-01/shutterstock_153551429.jpg)
Partnering Interests
Mental Health disorders
The development of new treatment options for Neuropsychiatric diseases is a key priority for Boehringer Ingelheim
Read more
![](/sites/default/files/us/partnering_content_card_images/shutterstock_172605095.jpg)
Partnering Interests
Oncology & Cancer Immunology
Our commitment to innovation in oncology research has resulted in the launch of two products for the treatment of non-small cell lung cancer.
Read more
![lung diseases graphic lung diseases graphic](/sites/default/files/us/2022-08/467846964%20Partnering%20Interests%20Respiratory.jpg)
Partnering Interests
Respiratory
Boehringer Ingelheim is a leader in respiratory medicine with a 100-year history of innovation in this area.
Read more
Downloads
![partnering contacts graphic partnering contacts graphic](/sites/default/files/us/partnering_content_card_images/04_worldwide_partnering_contacts.jpg)
Worldwide Partnering Contacts
![Lightbulbs with words reading together everyone achieves more Lightbulbs with words reading together everyone achieves more](/sites/default/files/us/2023-01/partnering-interests.jpg)
Partnering with Boehringer Ingelheim
Find out more about how we can work together to advance innovation.